| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |